Top of page
Health

Two short strings of amino acids could pave the way to Alzheimer treatments

Two years after discovering a way to neutralize a rogue protein linked to Alzheimer’s disease, University of Alberta Distinguished University Professor and neurologist Jack Jhamandas has found a new piece of the Alzheimer’s puzzle, bringing him closer to a treatment for the disease.

In a study published in Scientific Reports, Jhamandas and his team found two short peptides, or strings of amino acids, that when injected into mice with Alzheimer’s disease daily for five weeks, significantly improved the mice’s memory. The treatment also reduced some of the harmful physical changes in the brain that are associated with the disease.

“In the mice that received the drugs, we found less amyloid plaque buildup and a reduction in brain inflammation,” said Jhamandas, who is also a member of the Neuroscience and Mental Health Institute.

“So this was very interesting and exciting because it showed us that not only was memory being improved in the mice, but signs of brain pathology in Alzheimer’s disease were also greatly improved. That was a bit of a surprise for us.”

Read the full story at www.folio.ca

You might also like

A disabled girl being lifted into a wheelchair with help from a special lift operated by a care assistant. A disabled girl being lifted into a wheelchair with help from a special lift operated by a care assistant.

12,000 people in UK become unpaid carers every day

Around 12,000 people become unpaid carers every day in the…

Alzheimer's Patient Alzheimer's Patient

Aged care collapsing as phase two of pay case kicks off

Aged care collapsing as phase two of pay case kicks…

Nurse talking with patient in wheelchair Nurse talking with patient in wheelchair

Enrollment and eligibility for Medicare for people with disabilities

Medicare is a government program designed to provide medical coverage…

microscopic photo of coronavirus microscopic photo of coronavirus

More caution in health services as cases rise

NSW Health has upgraded its COVID-19 risk rating to amber…